U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: June 20-26, 2021
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: June 20-26, 2021

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Janet Woodcock, M.D., Acting Commissioner

Event Date: 06/22/2021
Location: Virtual
Subject: 15th Annual BioPharma and Healthcare Summit
FDA Participant/Group: N/A
Non FDA Participant/Group: Government, industry, academia, media, and other registered guests

Event Date: 06/22/2021
Location: Virtual
Subject: World Local Production Forum: Enhancing Access to Medicine and Other Health Technologies
FDA Participant/Group: N/A
Non FDA Participant/Group: Government, industry, academia, and other registered guests

Event Date: 06/23/2021
Location: Virtual
Subject: Trial Updates and Protocols
FDA Participant/Group: PETER STEIN;
Non FDA Participant/Group: Parties involved in Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV)

Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 06/22/2021
Location: Virtual
Subject: Panelist: Blockchain Technology and Applications with Food
FDA Participant/Group: N/A
Non FDA Participant/Group: Executives from across the technology and food industries

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Erica Jefferson, Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

Event Date: 06/22/2021
Location: Virtual
Subject: FDA - Arthritis Foundation (AF) Osteoarthritis Drug Drug Development Workshop
FDA Participant/Group: RAJ NAIR; SAHAR DAWISHA; SILVANA BORGES; ERIC GAPUD; SADAF NABAVIAN; NIKOLAY NIKOLOV; RACHEL GLASER; YURA KIM; AMIT GOLDING; LARISSA LAPTEVA; ROBERT SHIBUYA;
Non FDA Participant/Group: Ali Mobasheri, David Felson, Jason Kim, Kurt Spindler, Xiaojuan Li (Arthritis Foundation (AF)); Xincheng Zheng (National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)); Ali Mobasheri (Osteoarthritis Research Society International (OARSI));

Event Date: 06/24/2021
Location: Virtual
Subject: International Coalition of Medicines Regulatory Authorities (ICMRA) Executive Committee Meeting; COVID-19 Vaccine Development: Future Steps
FDA Participant/Group: PETER MARKS;
Non FDA Participant/Group: June Raine (Medicines and Healthcare Regulatory Agency (MHRA)); Yasuhiro Fujiwara (Pharmaceuticals and Medical Devices Agency (PMDA));

Event Date: 06/25/2021
Location: Virtual
Subject: Duke - Margolis Project Updates and Planning; Roundtable on Payer Evidentiary
FDA Participant/Group: MICHELLE CAMPBELL;
Non FDA Participant/Group: Marianne Hamilton, Mark McClellan, Morgan Romine, Nitzan Arad (Duke-Margolis);

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 06/21/2021
Location: Virtual
Subject: Silicon Valley Bank Leerink CybeRx Series: Vaccine Forum
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of Silicon Valley Bank Leerink CybeRx Series: Vaccine Forum

Event Date: 06/22/2021
Location: Virtual
Subject: American Society of Gene + Cell Therapy Forum: Gene Therapy for Underserved Populations; Public-Private Partnership: Bespoke Gene Therapy Consortium
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of American Society of Gene + Cell Therapy Forum: Gene Therapy for Underserved Populations

Event Date: 06/25/2021
Location: Virtual
Subject: The COVID-19 and Cancer Consortium Quarterly Seminar; COVID-19 Vaccines in Patients with Cancer
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of The COVID-19 and Cancer Consortium Quarterly Seminar

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

Event Date: 06/24/2021
Location: Virtual
Subject: Society for Birth Defects Research & Prevention 61st Annual Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Government, industry, academia, and other invited guests

Official Name: Mark Raza, J.D., Acting Chief Counsel

No Significant Event

 

Back to Top